Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Sirolimus
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Vascular Therapies Completes Enrollment in Phase III ACCESS 2 Sirolimus Study
Details : Sirogen (sirolimus) for the surgical creation of arteriovenous (AV) fistula in patients requiring hemodialysis vascular access is being evaluated for Chronic Kidney Disease.
Product Name : Sirogen
Product Type : Antibiotic
Upfront Cash : Inapplicable
May 08, 2024
Lead Product(s) : Sirolimus
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sirolimus
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : $17.3 million
Deal Type : Financing
Vascular Therapies Completes Upsized $17.3 Million Private Financing
Details : Vascular Therapies plans to use the proceeds to further advance Sirogen, a proprietary sirolimus formulation for intraoperative, local, perivascular drug delivery.
Product Name : Sirogen
Product Type : Antibiotic
Upfront Cash : Undisclosed
January 28, 2020
Lead Product(s) : Sirolimus
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : $17.3 million
Deal Type : Financing